Page last updated: 2024-10-27

flutamide and Urinary Incontinence

flutamide has been researched along with Urinary Incontinence in 2 studies

Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.

Urinary Incontinence: Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.

Research Excerpts

ExcerptRelevanceReference
"Treatment of localized prostate cancer (PC) is controversial."2.80Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes. ( Albertsson, P; Brandberg, Y; Damber, JE; Damm, O; Holmberg, E; Isacsson, U; Lennernäs, B; Ljung, G; Majumder, K; Nilsson, S, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lennernäs, B1
Majumder, K1
Damber, JE1
Albertsson, P1
Holmberg, E1
Brandberg, Y1
Isacsson, U1
Ljung, G1
Damm, O1
Nilsson, S1
Miller, NL1
Bissonette, EA1
Bahnson, R1
Wilson, J1
Theodorescu, D1

Trials

1 trial available for flutamide and Urinary Incontinence

ArticleYear
Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cost of Illness; Emotions; Erec

2015

Other Studies

1 other study available for flutamide and Urinary Incontinence

ArticleYear
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
    Cancer, 2003, Mar-01, Volume: 97, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Brachytherapy; C

2003